|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 21/00 | (2006.01) |
| (11) | Number of the document | 2576618 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11726005.9 |
| Date of filing the European patent application | 2011-05-25 | |
| (97) | Date of publication of the European application | 2013-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-16 |
| (46) | Date of publication of the claims translation | 2017-10-25 |
| (86) | Number | PCT/US2011/037837 |
| Date | 2011-05-25 |
| (87) | Number | WO 2011/150008 |
| Date | 2011-12-01 |
| (30) | Number | Date | Country code |
| 348559 P | 2010-05-26 | US | |
| 372882 P | 2010-08-12 | US |
| (72) |
STITT, Trevor, US
LATRES, Esther, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnai prieš žmogaus GDF8 |
| ANTIBODIES TO HUMAN GDF8 |
| Payment date | Validity (years) | Amount | |
| 2026-04-21 | 16 | 347.00 EUR |
| 2027-05-25 |